FOXA1 is an essential determinant of ER alpha expression and mammary ductal morphogenesis
- Bernardo, GM; Lozada, KL; Miedler, JD; Harburg, G; Hewitt, SC; Mosley, JD; Godwin, AK; Korach, KS; Visvader, JE; Kaestner, KH; Abdul-Karim, FW; Montano, MM; Keri, RA;
Publication Year 2010-06-15, Volume 137, Issue #12, Page 2045-2054
- Journal Title
- Publication Type
- Journal Article
- FOXA1, estrogen receptor alpha (ER alpha) and GATA3 independently predict favorable outcome in breast cancer patients, and their expression correlates with a differentiated, luminal tumor subtype. As transcription factors, each functions in the morphogenesis of various organs, with ER alpha and GATA3 being established regulators of mammary gland development. Interdependency between these three factors in breast cancer and normal mammary development has been suggested, but the specific role for FOXA1 is not known. Herein, we report that Foxa1 deficiency causes a defect in hormone-induced mammary ductal invasion associated with a loss of terminal end bud formation and ER alpha expression. By contrast, Foxa1 null glands maintain GATA3 expression. Unlike ER alpha and GATA3 deficiency, Foxa1 null glands form milk-producing alveoli, indicating that the defect is restricted to expansion of the ductal epithelium, further emphasizing the novel role for FOXA1 in mammary morphogenesis. Using breast cancer cell lines, we also demonstrate that FOXA1 regulates ER alpha expression, but not GATA3. These data reveal that FOXA1 is necessary for hormonal responsiveness in the developing mammary gland and ER alpha-positive breast cancers, at least in part, through its control of ER alpha expression.
- COMPANY OF BIOLOGISTS LTD
- ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; GLAND DEVELOPMENT; PROGESTERONE-RECEPTOR; CELL DIFFERENTIATION; GLUCOSE-HOMEOSTASIS; IN-VIVO; GATA-3; MICE; PROLIFERATION
- Publisher's Version
- Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2010-06-15 12:00:00Last Modified: 0001-01-01 12:00:00